These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15715270)

  • 1. Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate).
    León-Sanz M; García-Luna PP; Sanz-París A; Gómez-Candela C; Casimiro C; Chamorro J; Pereira-Cunill JL; Martin-Palmero A; Trallero R; Martínez J; Ordóñez FJ; García-Peris P; Camarero E; Gómez-Enterría P; Cabrerizo L; Perez-de-la-Cruz A; Sánchez C; García-de-Lorenzo A; Rodríguez N; Usán L;
    JPEN J Parenter Enteral Nutr; 2005; 29(1):21-9. PubMed ID: 15715270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic Effects of a Low-Carbohydrate Enteral Formula Compared With an Enteral Formula of Standard Composition in Critically Ill Patients: An Open-Label Randomized Controlled Clinical Trial.
    van Steen SC; Rijkenberg S; Sechterberger MK; DeVries JH; van der Voort PHJ
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1035-1045. PubMed ID: 30133840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and lipid metabolism in patients with NIDDM.
    McCargar LJ; Innis SM; Bowron E; Leichter J; Dawson K; Toth E; Wall K
    Mol Cell Biochem; 1998 Nov; 188(1-2):81-9. PubMed ID: 9823014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas.
    Vanschoonbeek K; Lansink M; van Laere KM; Senden JM; Verdijk LB; van Loon LJ
    Diabetes Educ; 2009; 35(4):631-40. PubMed ID: 19448045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes.
    Voss AC; Maki KC; Garvey WT; Hustead DS; Alish C; Fix B; Mustad VA
    Nutrition; 2008 Oct; 24(10):990-7. PubMed ID: 18718737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-fat versus high-carbohydrate enteral formulae: effect on blood glucose, C-peptide, and ketones in patients with type 2 diabetes treated with insulin or sulfonylurea.
    Sanz-París A; Calvo L; Guallard A; Salazar I; Albero R
    Nutrition; 1998; 14(11-12):840-5. PubMed ID: 9834926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label, randomized, multiple-center, parallel study comparing glycemic responses and safety profiles of Glucerna versus Fresubin in subjects of type 2 diabetes mellitus.
    Wang WQ; Zhang YF; Zhou DJ; Liu ZM; Hong X; Qiu MC; Shi YQ; Xia PJ; Lu J; Xu MJ; An L; Feng W; Zhang P; Schwamman J; Ning G
    Endocrine; 2008 Feb; 33(1):45-52. PubMed ID: 18401766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with modified enteral formulas for patients with diabetes.
    Coulston AM
    Clin Nutr; 1998 Sep; 17 Suppl 2():46-56. PubMed ID: 10205359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of different nutritional feeds on the postprandial glucose response in healthy volunteers and patients with type II diabetes.
    Hofman Z; van Drunen JD; de Later C; Kuipers H
    Eur J Clin Nutr; 2004 Nov; 58(11):1553-6. PubMed ID: 15173856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial.
    Pohl M; Mayr P; Mertl-Roetzer M; Lauster F; Lerch M; Eriksen J; Haslbeck M; Rahlfs VW
    Eur J Clin Nutr; 2005 Nov; 59(11):1221-32. PubMed ID: 16077745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a novel palatinose based enteral formula (MHN-01) carbohydrate-adjusted fluid diet in improving the metabolism of carbohydrates and lipids in patients with esophageal cancer complicated by diabetes mellitus.
    Fujiwara T; Naomoto Y; Motoki T; Shigemitsu K; Shirakawa Y; Yamatsuji T; Kataoka M; Haisa M; Fujiwara T; Egi M; Morimatsu H; Hanazaki M; Katayama H; Morita K; Mizumoto K; Asou T; Arima H; Sasaki H; Matsuura M; Gunduz M; Tanaka N
    J Surg Res; 2007 Apr; 138(2):231-40. PubMed ID: 17254607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes-Specific Complete Smoothie Formulas Improve Postprandial Glycemic Response in Obese Type 2 Diabetic Individuals: A Randomized Crossover Trial.
    Mongkolsucharitkul P; Pinsawas B; Surawit A; Pongkunakorn T; Manosan T; Ophakas S; Suta S; Pumeiam S; Mayurasakorn K
    Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial.
    Craig LD; Nicholson S; SilVerstone FA; Kennedy RD
    Nutrition; 1998 Jun; 14(6):529-34. PubMed ID: 9646297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the metabolism of postprandial lipoproteins after a high-monounsaturated-fat versus a high-carbohydrate diet in patients with type 1 diabetes mellitus.
    Georgopoulos A; Bantle JP; Noutsou M; Swaim WR; Parker SJ
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):773-82. PubMed ID: 9598837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various enteral feeding products on postprandial blood glucose response in patients with type I diabetes.
    Peters AL; Davidson MB
    JPEN J Parenter Enteral Nutr; 1992; 16(1):69-74. PubMed ID: 1738224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial.
    Pohl M; Mayr P; Mertl-Roetzer M; Lauster F; Haslbeck M; Hipper B; Steube D; Tietjen M; Eriksen J; Rahlfs VW
    JPEN J Parenter Enteral Nutr; 2009; 33(1):37-49. PubMed ID: 19011146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a high-monounsaturated-fat diet on lipid profile in subjects with type 1 diabetes.
    Strychar I; Ishac A; Rivard M; Lussier-Cacan S; Beauregard H; Aris-Jilwan N; Radwan F; Yale JF
    J Am Diet Assoc; 2003 Apr; 103(4):467-74. PubMed ID: 12669010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very high-protein and low-carbohydrate enteral nutrition formula and plasma glucose control in adults with type 2 diabetes mellitus: a randomized crossover trial.
    Huhmann MB; Yamamoto S; Neutel JM; Cohen SS; Ochoa Gautier JB
    Nutr Diabetes; 2018 Aug; 8(1):45. PubMed ID: 30158516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-monounsaturated fatty acid enteral formula versus high-carbohydrate enteral formula on plasma glucose concentration and insulin secretion in healthy individuals and diabetic patients.
    Yokoyama J; Someya Y; Yoshihara R; Ishii H
    J Int Med Res; 2008; 36(1):137-46. PubMed ID: 18230277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a Low-carbohydrate Enteral Nutrition Formula with Effective Inhibition of Hypoglycemia and Post-infusion Hyperglycemia in Non-diabetic Patients Fed via a Jejunostomy Tube.
    Nishiwaki S; Fujimoto H; Kurobe T; Baba A; Iwashita M; Hatakeyama H; Hayashi T; Maeda T
    Intern Med; 2020 Aug; 59(15):1803-1809. PubMed ID: 32461526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.